Quark Venture Inc. — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Microbionmicrobioncorp.comDec 2016✓ verified
Microbion develops therapeutics targeting biofilm-associated infections, with a lead candidate (Pravibismane) in clinical development for diabetic foot ulcer, orthopedic implant, and respiratory infections.
BiotechHealthtechMedical DevicesBozeman, US
Karim Lalji(Executive Officer, Director)inFrank Kerins(Executive Officer)Brett Baker(Founder, President & Chief Innovation Officer)
BoardRodger May(Director)Jared Carney(Director)Steven Schellong(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
